Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Boston Scientific Hooks In Millipede, But Still Trailing Behind In Mitral Valve Race

Executive Summary

Boston Scientific is pumping money into the high-potential mitral valve repair space by making a strategic investment in Millipede, as well as signing an acquisition option agreement that could be worth nearly half a billion dollars. However, its cardiovascular rivals are already some distance ahead in this space.


Related Content

Boston Scientific Makes A Move In Mitral Valve, Sealing $325M Deal With Millipede
M&A Analysis: January, Crisp Start To The Year
VC Deals Analysis: 2018 Off To A Flying Start
Starts & Stops: 2017 Finishes With Progress For Edwards, Stalled Trials For Boston Scientific
Edwards Adds To Wide Range Of Approaches To Mitral Repair
Symetis TAVR Buy Not About Throwing Shade On Lotus, BSX Insists


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts